M. Bret Schneider
Corporate Officer/Principal bei Stanford University
Aktive Positionen von M. Bret Schneider
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stanford University | Corporate Officer/Principal | - | - |
Karriereverlauf von M. Bret Schneider
Ehemalige bekannte Positionen von M. Bret Schneider
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cervel Neurotech, Inc.
 Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.02.2010 | - | |
| Gründer | 15.04.2011 | - |
Ausbildung von M. Bret Schneider
| Washington University in St. Louis | Undergraduate Degree |
| Rush University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Cervel Neurotech, Inc.
Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Health Technology |
- Börse
- Insiders
- M. Bret Schneider
- Erfahrung